ArticleCancer immunology, immunotherapy : CII2018

Tumor infiltrating lymphocytes in lymph node metastases of stage III melanoma correspond to response and survival in nine patients treated with ipilimumab at the time of stage IV disease.

Stefan Diem et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.